Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Gyre Therapeutics (GYRE)

Gyre Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GYRE
DateTimeSourceHeadlineSymbolCompany
18/06/202421:05GlobeNewswire Inc.Gyre Therapeutics Announces Publication in Journal of Gastroenterology and HepatologyNASDAQ:GYREGyre Therapeutics Inc
17/06/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GYREGyre Therapeutics Inc
30/05/202421:06Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GYREGyre Therapeutics Inc
30/05/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GYREGyre Therapeutics Inc
30/05/202421:05GlobeNewswire Inc.Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial HypertensionNASDAQ:GYREGyre Therapeutics Inc
30/05/202421:02Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GYREGyre Therapeutics Inc
28/05/202421:05GlobeNewswire Inc.Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® IndexesNASDAQ:GYREGyre Therapeutics Inc
13/05/202421:07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GYREGyre Therapeutics Inc
09/05/202421:10GlobeNewswire Inc.Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:GYREGyre Therapeutics Inc
09/05/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GYREGyre Therapeutics Inc
08/05/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GYREGyre Therapeutics Inc
26/03/202410:00GlobeNewswire Inc.Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:GYREGyre Therapeutics Inc
21/03/202411:00GlobeNewswire Inc.Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. NussbaumNASDAQ:GYREGyre Therapeutics Inc
15/12/202314:04PR Newswire (US)Totus Medicines Announces Appointment of Nassim Usman, Ph.D., as President & CEO and the Closing of a $66M Series B FundingNASDAQ:GYREGyre Therapeutics Inc
13/11/202312:00GlobeNewswire Inc.Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver MeetingNASDAQ:GYREGyre Therapeutics Inc
02/11/202321:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GYREGyre Therapeutics Inc
01/11/202321:18Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:GYREGyre Therapeutics Inc
01/11/202320:58Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:GYREGyre Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:GYRE